Subscribe To
IPHA / Innate Pharma to Participate in Upcoming Investor Conferences
IPHA News
By Business Wire
October 27, 2023
Innate Pharma Announces Its Participation to Upcoming Investor Conferences
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Business Wire
August 29, 2023
Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Business Wire
June 12, 2023
Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Zacks Investment Research
June 9, 2023
Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag
Innate (IPHA) and Sanofi's SAR'579 / IPH6101 get Fast Track Designation in the United States for the treatment of hematological malignancies. more_horizontal
By The Motley Fool
June 8, 2023
Why Shares of Innate Pharma Jumped Thursday
A therapy Innate Pharma and Sanofi are developing was granted Fast Track Designation by the FDA. Innate Pharma has enough cash to fund operations into more_horizontal
By Business Wire
May 23, 2023
Innate Pharma to Participate in Upcoming Investor Conferences
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Business Wire
May 15, 2023
Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Seeking Alpha
May 13, 2023
Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript
Innate Pharma SA (NASDAQ:IPHA ) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Henry Wheeler - VP, IR & Communication M more_horizontal
